Abstract
Background
Bacillus thuringiensis (Bt) is a widely used biopesticide. The bioinsecticide based on Bt is obtained by fermentation, but the substrates currently used for its production constitute ingredients of high commercial value. In this context, the use of agro-industrial residues as substrates is an alternative to make the fermentation process viable on a large scale, in addition to minimizing environmental problems and contributing to the destination of these residues for biotechnological purposes.
Results
In the first part of this study, a previously isolated spore forming soil bacteria (Bv5) harboring and expressing a novel cry 8A gene was confirmed as B. thuringiensis based on its morphological characteristics, Gram staining, scanning electron microscopy (SEM) and genome sequencing. Bv5 was established as a Gram-positive spore forming bacteria with ellipsoidal spores and small round toxins. Bv5 genome comprised of the 5.30 Mb chromosome and two megaplasmids of 450 kb and 261 kb, respectively, with cry 8A gene located on the smallest megaplasmid. In the second part of the study, the physiological profile of the Bv5 strain during fermentation in different agro-industrial biowastes (cassava wastewater, orange pulp wash and whey) was analyzed. The fermentation experiment was divided into two stages. In the first stage, the agro-industrial waste with or without salts with the best results for biomass, spores and proteins production was selected. In the second stage, the effect of the selected medium in original and diluted form with the C:N balance was evaluated, in two different fermentation times (72 h and 96 h). Pulp wash enriched with salts was selected as the most suitable medium for the growth of Bv5 strain in the first stage. In the second stage pulp wash (without dilution) with the addition of salts, and with nitrogen supplementation, was considered the best for cell growth, spore and toxin production by Bv5.
Conclusions
To conclude, our study provide a new alternative for bio-waste from the orange juice industry, as well as potential culture medium for the Bt commercial scale production.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Dolabella, Silvio S. 7 ; da C. Mendonça, Marcelo 1 ; Jain, Sona 1 1 University of Tiradentes (UNIT), Industrial Biotechnology Program, Aracaju, Brazil (GRID:grid.442005.7) (ISNI:0000 0004 0616 7223)
2 Empresa de Desenvolvimento Agropecuário Do Estado de Sergipe (EMDAGRO), Laboratório de Controle Biotecnológico de Pagas (LCBiotec), São Cristóvão, Brazil (GRID:grid.442005.7)
3 Institute of Technology and Research, Laboratory of Colloidal Systems Studies, Aracaju, Brazil (GRID:grid.442005.7)
4 Federal University of Sergipe, Department of Biology, São Cristóvão, Brazil (GRID:grid.411252.1) (ISNI:0000 0001 2285 6801)
5 Federal University of Sergipe, Department of Physiology, São Cristóvão, Brazil (GRID:grid.411252.1) (ISNI:0000 0001 2285 6801)
6 University of Porto, UCIBIO – Applied Molecular Biosciences Unit, MEDTECH, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); University of Porto, Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226)
7 Federal University of Sergipe, Department of Morphology, São Cristóvão, Brazil (GRID:grid.411252.1) (ISNI:0000 0001 2285 6801)





